Susquehanna International Group
FLGT icon

Susquehanna International Group’s Fulgent Genetics FLGT Stock Holding History

Susquehanna International Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240K Sell
15,100
-3,800
-20% -$82.5K ﹤0.01% 11350
2025
Q4 		$497K Buy
+18,900
New +$490K ﹤0.01% 8804
2025
Q2 		– Sell
-13,900
Closed -$235K – 12954
2025
Q1 		$235K Buy
13,900
+500
+4% +$8.52K ﹤0.01% 10603
2024
Q4 		$247K Buy
+13,400
New +$262K ﹤0.01% 10234
2024
Q3 		– Sell
-10,100
Closed -$198K – 12291
2024
Q2 		$198K Sell
10,100
-31,800
-76% -$664K ﹤0.01% 10369
2024
Q1 		$909K Buy
41,900
+11,200
+36% +$278K ﹤0.01% 7139
2023
Q4 		$888K Buy
30,700
+8,800
+40% +$235K ﹤0.01% 7282
2023
Q3 		$586K Sell
21,900
-32,600
-60% -$1.11M ﹤0.01% 7861
2023
Q2 		$2.02M Buy
54,500
+6,800
+14% +$237K ﹤0.01% 5143
2023
Q1 		$1.49M Sell
47,700
-45,600
-49% -$1.47M ﹤0.01% 5821
2022
Q4 		$2.78M Sell
93,300
-60,800
-39% -$2.18M ﹤0.01% 4136
2022
Q3 		$5.87M Sell
154,100
-44,900
-23% -$2.25M ﹤0.01% 2914
2022
Q2 		$10.9M Sell
199,000
-6,800
-3% -$374K ﹤0.01% 2102
2022
Q1 		$12.8M Sell
205,800
-16,500
-7% -$1.09M ﹤0.01% 2227
2021
Q4 		$22.4M Sell
222,300
-82,200
-27% -$7.22M ﹤0.01% 1743
2021
Q3 		$27.4M Sell
304,500
-67,500
-18% -$6.13M ﹤0.01% 1673
2021
Q2 		$34.3M Buy
372,000
+36,700
+11% +$2.93M ﹤0.01% 1487
2021
Q1 		$32.4M Buy
335,300
+161,900
+93% +$16.7M 0.01% 1421
2020
Q4 		$9.03M Buy
173,400
+126,400
+269% +$5.28M ﹤0.01% 2619
2020
Q3 		$1.88M Buy
+47,000
New +$1.47M ﹤0.01% 4738

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's FLGT Position: Q1 2026 in Review

Susquehanna International Group increased its Fulgent Genetics (FLGT) stake by 254% in Q1 2026, buying an estimated $593K and bringing the position to 38,078 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #9169.

Susquehanna International Group first reported a position in FLGT in Q1 2018 and has held it in 25 quarters since. The position peaked at $15.2M in Q2 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Susquehanna International Group held 38,078 shares of Fulgent Genetics worth $605K as of Q1 2026.
  • Susquehanna International Group bought 27,310 Fulgent Genetics shares in Q1 2026, an estimated $593K.
  • Fulgent Genetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9169 holding.
  • Susquehanna International Group first reported a position in Fulgent Genetics in Q1 2018 and has held it in 25 quarters since.
  • Susquehanna International Group's Fulgent Genetics position peaked at $15.2M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.